4-chlorophenyl methyl sulfide and Multiple Myeloma

4-chlorophenyl methyl sulfide has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aboagye, E; Barfoot, T; Barwick, T; Doran, S; Glocker, B; Greenlay, E; Kaiser, M; Koh, DM; Leach, MO; Li, X; Messiou, C; Qaiser, T; Rockall, A; Satchwell, L; Wedlake, L; Winzeck, S	1

Trials

1 trial(s) available for 4-chlorophenyl methyl sulfide and Multiple Myeloma

Article	Year
Development of machine learning support for reading whole body diffusion-weighted MRI (WB-MRI) in myeloma for the detection and quantification of the extent of disease before and after treatment (MALIMAR): protocol for a cross-sectional diagnostic test ac BMJ open, 2022, 10-05, Volume: 12, Issue:10 Topics: Chlorobenzenes; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Sectional Studies; Diagnostic Tests, Routine; Humans; Machine Learning; Magnetic Resonance Imaging; Multiple Myeloma; Retrospective Studies; Sulfides; Whole Body Imaging	2022

Article

Year

Development of machine learning support for reading whole body diffusion-weighted MRI (WB-MRI) in myeloma for the detection and quantification of the extent of disease before and after treatment (MALIMAR): protocol for a cross-sectional diagnostic test ac

BMJ open, 2022, 10-05, Volume: 12, Issue:10

Topics: Chlorobenzenes; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Sectional Studies; Diagnostic Tests, Routine; Humans; Machine Learning; Magnetic Resonance Imaging; Multiple Myeloma; Retrospective Studies; Sulfides; Whole Body Imaging

2022